Suppr超能文献

优化跨心灌注以更准确评估大分子的生物分布。

Optimization of Transcardiac Perfusion for More Accurately Evaluating Biodistribution of Large Molecules.

机构信息

Drug Metabolism and Pharmacokinetics, Biogen, Cambridge, MA 02142, USA.

出版信息

Int J Mol Sci. 2024 Nov 13;25(22):12180. doi: 10.3390/ijms252212180.

Abstract

The accurate assessment of drug concentrations in biodistribution studies is crucial for evaluating the efficacy and toxicity of compounds in drug development. As the concentration of biologics in plasma can be higher than in tissue due to their potentially low volume of distribution, transcardiac perfusion is commonly employed to reduce the influence of excess drugs in residual blood. However, there is a lack of consistency in the literature on the conditions and methods of perfusion. To enhance blood removal during transcardiac perfusion, sodium nitrite (NaNO), a vasodilator, has been widely used with concentrations up to 5% in publications. However, we found that such high NaNO could disrupt the BBB during perfusion, which should be avoided in experiments. In this study, we examined the impact of various vasodilators on blood-brain barrier integrity and vascular permeability using the ratio of FITC-Dextran to Texas Red-Dextran (FITC/Texas Red). Additionally, we optimized perfusion conditions-including euthanasia method and perfusion flow rate-based on hemoglobin levels and the FITC/Texas Red ratio in tissues. Despite the superiority of NaNO in terms of solubility and cost over other vasodilators, we found that 2% NaNO disrupted blood-brain barrier integrity, significantly altering the FITC/Texas Red ratio. In contrast, 100 mM NaNO did not significantly affect this ratio. Moreover, under Ketamine/Xylazine (Ket/Xyl) anesthesia, which reduced blood clot formation compared to CO euthanasia, 100 mM NaNO achieved the lowest hemoglobin levels in the brain. Compared to other vasodilators and the PBS control group, 100 mM NaNO decreased the tissue/plasma ratio (K) but not brain/plasma ratio (K) of hIgG1 and human transferrin. We have developed a method to efficiently evaluate blood-brain barrier integrity during transcardiac perfusion. The combination of Ket/Xyl anesthesia and 100 mM NaNO effectively removes residual blood from tissues without significantly affecting blood vessel permeability.

摘要

在生物分布研究中准确评估药物浓度对于评估化合物在药物开发中的疗效和毒性至关重要。由于生物制剂在血浆中的浓度可能由于其潜在的低分布容积而高于组织中的浓度,因此通常采用心脏灌注来减少残留血液中过量药物的影响。然而,在文献中,关于灌注的条件和方法缺乏一致性。为了增强心脏灌注过程中的血液清除,血管扩张剂亚硝酸钠(NaNO)已被广泛使用,其在文献中的浓度高达 5%。然而,我们发现如此高的 NaNO 在灌注过程中可能会破坏血脑屏障,在实验中应避免使用。在这项研究中,我们使用 FITC-右旋糖酐与 Texas Red-右旋糖酐(FITC/Texas Red)的比例来研究各种血管扩张剂对血脑屏障完整性和血管通透性的影响。此外,我们根据组织中的血红蛋白水平和 FITC/Texas Red 比值优化了灌注条件,包括安乐死方法和灌注流速。尽管 NaNO 在溶解度和成本方面优于其他血管扩张剂,但我们发现 2%的 NaNO 破坏了血脑屏障的完整性,显著改变了 FITC/Texas Red 的比值。相比之下,100 mM 的 NaNO 对其比值没有显著影响。此外,与 CO 安乐死相比,在降低血液凝块形成的氯胺酮/甲苯噻嗪(Ket/Xyl)麻醉下,100 mM 的 NaNO 在大脑中达到了最低的血红蛋白水平。与其他血管扩张剂和 PBS 对照组相比,100 mM 的 NaNO 降低了 hIgG1 和人转铁蛋白的组织/血浆比(K),但不降低脑/血浆比(K)。我们已经开发出一种在心脏灌注过程中有效评估血脑屏障完整性的方法。Ket/Xyl 麻醉和 100 mM NaNO 的组合可有效清除组织中的残留血液,而不会显著影响血管通透性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验